Chimeric antigen receptor cells for treating solid tumor
US11161913B2 · kind B2 · utility
0Cited by
4References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 1, 2021 |
| Grant date | Nov 2, 2021 |
| Priority date | — |
| Expiry date | Apr 1, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2510/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The compositions and methods described herein are directed to treating solid tumor using CAR T therapy. The compositions include CAR comprising an extracellular domain that binds a siglec protein or a receptor that binds the peptide hormone kisspeptin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.